Jianan Chen

Jianan Chen

Auto-generated profile, based on publicly available information

Jianan Chen

Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2019 in Science
Verified
Journal Article
Closed access
PDF file
JYJunhua Yang
Junhua Yang
JCJianan Chen
Jianan Chen
MVMaria del Carmen Vitery
Maria del Carmen Vitery
JOJames Osei-Owusu
James Osei-Owusu
JCJiachen Chu
Jiachen Chu
ZQZhaozhu Qiu
Zhaozhu Qiu
A new protein channel family: Exposure of cells to acidic conditions outside the cell activates chloride-conducting channels that influence physiological and pathological processes. Yang et al. used an unbiased RNA interference screen to identify the channel protein that allows such proton-activated ion conductance. The protein, called PAC for proton-activated channel, has two predicted transmembrane domains and is unlike any previously identified channel. Identification of the channel should advance studies of its physiological roles, which range from tissue injury after stroke to adaptation of Tibetan natives to a high-altitude environment. Science , this issue p. 395

31 March 2023 in Science Advances
Verified
Journal Article
Closed access
JCJiachen Chu
Jiachen Chu
JYJunhua Yang
Junhua Yang
YZYuan Zhou
Yuan Zhou
JCJianan Chen
Jianan Chen
KCKevin Hong Chen
Kevin Hong Chen
ZQZhaozhu Qiu
Zhaozhu Qiu
Following peripheral nerve injury, extracellular adenosine 5′-triphosphate (ATP)–mediated purinergic signaling is crucial for spinal cord microglia activation and neuropathic pain. However, the mechanisms of ATP release remain poorly understood. Here, we show that volume-regulated anion channel (VRAC) is an ATP-releasing channel and is activated by inflammatory mediator sphingosine-1-phosphate (S1P) in microglia. Mice with microglia-specific deletion of Swell1 (also known as Lrrc8a), a VRAC essential subunit, had reduced peripheral nerve injury–induced increase in extracellular ATP in spinal cord. The mutant mice also exhibited decreased spinal microgliosis, dorsal horn neuronal hyperactivity, and both evoked and spontaneous neuropathic pain–like behaviors. We further performed high-throughput screens and identified an FDA-approved drug dicumarol as a novel and potent VRAC inhibitor. Intrathecal administration of dicumarol alleviated nerve injury–induced mechanical allodynia in mice. Our findings suggest that ATP-releasing VRAC in microglia is a key spinal cord determinant of neuropathic pain and a potential therapeutic target for this debilitating disease.